About: Tumour MHC class I downregulation and immunotherapy (Review).

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tumour MHC class I downregulation and immunotherapy (Review). Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	The purpose of this review is to discuss the positive results of MHC class I- tumour treatment obtained with immunomodulatory cytokines and tumour vaccines, as well as the prospects and limitations of such therapy. The purpose of this review is to discuss the positive results of MHC class I- tumour treatment obtained with immunomodulatory cytokines and tumour vaccines, as well as the prospects and limitations of such therapy. (en)
Title	Tumour MHC class I downregulation and immunotherapy (Review). Tumour MHC class I downregulation and immunotherapy (Review). (en)
skos:prefLabel	Tumour MHC class I downregulation and immunotherapy (Review). Tumour MHC class I downregulation and immunotherapy (Review). (en)
skos:notation	RIV/68378050:_____/03:23033193!RIV/2004/GA0/A23004/N
http://linked.open.../vavai/riv/strany	2005;2008
http://linked.open...avai/riv/aktivita	P Z
http://linked.open...avai/riv/aktivity	P(GA301/01/0985), P(IAA5052203), P(NC7148), Z(AV0Z5052915)
http://linked.open...iv/cisloPeriodika	6
http://linked.open...vai/riv/dodaniDat	2004
http://linked.open...aciTvurceVysledku	Bubeník, Jan
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav molekulární genetiky AV ČR, v. v. i.
http://linked.open...dnocenehoVysledku	631669
http://linked.open...ai/riv/idVysledku	RIV/68378050:_____/03:23033193
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	tumour vaccines; MHC class I downregulation (en)
http://linked.open.../riv/klicoveSlovo	tumour vaccines MHC class I downregulation
http://linked.open...odStatuVydavatele	GR - Řecká republika
http://linked.open...ontrolniKodProRIV	[90BAD54EC510]
http://linked.open...i/riv/nazevZdroje	Oncology Reports
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	1 (xsd:int)
http://linked.open...ocetUcastnikuAkce	0 (xsd:int)
http://linked.open...nichUcastnikuAkce	0 (xsd:int)
http://linked.open...vavai/riv/projekt	Combined therapy of metastazising tumours induced by HPV 16 E8/E7 and ras oncogenes Tumour vaccines constructed by fusion of tumour and dendritic cells Vaccination against two types (MHC I+ and MHC I-) of tumours induced by E6/E7 HPV16 viral oncogenes.
http://linked.open...UplatneniVysledku	2003
http://linked.open...v/svazekPeriodika	10
http://linked.open...iv/tvurceVysledku	Bubeník, Jan
http://linked.open...n/vavai/riv/zamer	Regulace a signální cesty uplatňující se v genové expresi, imunitě, onkogenezi, replikaci virů, tvorbě buněčných struktur, chování buněk, vývoji a oplození
issn	1021-335X
number of pages	4 (xsd:int)

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 35 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software